An overview on peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan
- PMID: 12365859
- DOI: 10.1177/000331970205300505
An overview on peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan
Abstract
The arsenic-related peripheral vascular disease found to be endemic along the southwestern coast of Taiwan is reviewed. In the early 20th century a strange disease involving the lower extremities characterized by typical clinical symptoms and signs of progressive arterial occlusion was reported in a confined area located along the southwestern coast of Taiwan. The disease was locally called "blackfoot disease" because of its gangrenous appearance involving the feet of the patients. The prevalence of this disease ranged from 6.51 to 18.85 per 1,000 population in different villages. Epidemiologic studies revealed that blackfoot disease was associated with the consumption of artesian well water containing high levels of arsenic. High co-occurrence of blackfoot disease and arsenic-related skin lesions such as hyperpigmentation, hyperkeratosis, and skin cancer was also observed. Recent studies also confirmed the association of preclinical peripheral vascular disease with arsenic exposure in a dose-response pattern. Subclinical arterial insufficiency and defects in cutaneous microcirculation can also be demonstrated in seemingly normal subjects living in the endemic villages. The incidence of clinical manifestation of blackfoot disease decreased dramatically after the implementation of tap water in these villages over the past 2-3 decades. The atherogenicity of arsenic could be associated with its effects on hypercoagulability, endothelial injury, smooth muscle cell proliferation, somatic mutation, oxidative stress, and apoptosis. However, its interaction with some trace elements and its association with hypertension and diabetes mellitus could also explain part of its higher risk of developing atherosclerosis.
Similar articles
-
Blackfoot disease and arsenic: a never-ending story.J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2005;23(1):55-74. doi: 10.1081/GNC-200051860. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2005. PMID: 16291522 Review.
-
Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan.Atherosclerosis. 1996 Feb;120(1-2):125-33. doi: 10.1016/0021-9150(95)05693-9. Atherosclerosis. 1996. PMID: 8645353
-
Defective adrenergic responses in patients with arsenic-induced peripheral vascular disease.Angiology. 2007 Apr-May;58(2):161-8. doi: 10.1177/0003319707300351. Angiology. 2007. PMID: 17495264
-
Cardiovascular disease in arsenic-exposed subjects living in the arseniasis-hyperendemic areas in Taiwan.Atherosclerosis. 2008 Jul;199(1):12-8. doi: 10.1016/j.atherosclerosis.2008.02.013. Epub 2008 Feb 21. Atherosclerosis. 2008. PMID: 18367191 Review.
-
Effects and dose--response relationships of skin cancer and blackfoot disease with arsenic.Environ Health Perspect. 1977 Aug;19:109-19. doi: 10.1289/ehp.7719109. Environ Health Perspect. 1977. PMID: 908285 Free PMC article.
Cited by
-
Mechanisms pertaining to arsenic toxicity.Toxicol Int. 2011 Jul;18(2):87-93. doi: 10.4103/0971-6580.84258. Toxicol Int. 2011. PMID: 21976811 Free PMC article.
-
Hepatic and Nephric NRF2 Pathway Up-Regulation, an Early Antioxidant Response, in Acute Arsenic-Exposed Mice.Int J Environ Res Public Health. 2015 Oct 12;12(10):12628-42. doi: 10.3390/ijerph121012628. Int J Environ Res Public Health. 2015. PMID: 26473898 Free PMC article.
-
Developmental and genetic modulation of arsenic biotransformation: a gene by environment interaction?Toxicol Appl Pharmacol. 2007 Aug 1;222(3):381-7. doi: 10.1016/j.taap.2006.12.018. Epub 2006 Dec 23. Toxicol Appl Pharmacol. 2007. PMID: 17306849 Free PMC article.
-
Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study.Lancet. 2010 Jul 24;376(9737):252-8. doi: 10.1016/S0140-6736(10)60481-3. Epub 2010 Jun 18. Lancet. 2010. PMID: 20646756 Free PMC article.
-
Glucogallin Attenuates RAW 264.7 Cells from Arsenic Trioxide Induced Toxicity via the NF-ҡB/NLRP3 Pathway.Molecules. 2022 Aug 18;27(16):5263. doi: 10.3390/molecules27165263. Molecules. 2022. PMID: 36014502 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous